Verschuur H P, Marcy P Y, Granon C, Bensadoun R J, Dassonville O, Schneider M, Demard F
Department of Otorhinolaryngology, Centre Antoine Lacassagne, Nice, France.
Am J Otolaryngol. 1997 May-Jun;18(3):190-6. doi: 10.1016/s0196-0709(97)90081-8.
Despite its high response rate, the use of neoadjuvant chemotherapy remains controversial. Pretherapeutic identification of subgroups of patients who are likely to respond to chemotherapy is of the utmost importance.
In this study, we have attempted to determine the relationship between specific radiological parameters and the response to neoadjuvant chemotherapy. In addition, we have determined if these parameters could yield prognostic information on recurrence and/or survival.
Fifty-four patients with a squamous cell carcinoma of the oral cavity or base of tongue who had had a contrast-enhanced CT scan and neoadjuvant chemotherapy were included in this analysis. All clinical, radiological, surgical, histological, and radiotherapeutical parameters as well as the follow-up data were analyzed by a chi-square test. The method of Kaplan-Meyer was used to determine disease-free intervals and crude survival. The log-rank method was used for testing differences in local failures and survival.
Twenty-eight patients were classified as having isodense nodes and 20 patients as having hypodense nodes. Nodal density was not related to tumor size or primary site. N stage was not correlated with the density of the nodes. Patients with hypodense nodes had a significantly lower disease-free interval and survival than patients with isodense nodes. The relation between overall response to chemotherapy and the hypodensity of the nodes didn't reach a significant level.
No relation was found between overall response to chemotherapy and N-stage or tumor density. Disease-free interval and crude survival was strongly related to response to chemotherapy.
尽管新辅助化疗的缓解率很高,但其应用仍存在争议。治疗前识别可能对化疗有反应的患者亚组至关重要。
在本研究中,我们试图确定特定的放射学参数与新辅助化疗反应之间的关系。此外,我们还确定了这些参数是否能提供有关复发和/或生存的预后信息。
本分析纳入了54例口腔或舌根鳞状细胞癌患者,这些患者均接受了增强CT扫描和新辅助化疗。所有临床、放射学、手术、组织学和放射治疗参数以及随访数据均采用卡方检验进行分析。采用Kaplan-Meier方法确定无病间期和总生存率。采用对数秩检验法检验局部复发和生存率的差异。
28例患者的淋巴结为等密度,20例患者的淋巴结为低密度。淋巴结密度与肿瘤大小或原发部位无关。N分期与淋巴结密度无关。低密度淋巴结患者的无病间期和生存率显著低于等密度淋巴结患者。化疗的总体反应与淋巴结低密度之间的关系未达到显著水平。
化疗的总体反应与N分期或肿瘤密度之间未发现相关性。无病间期和总生存率与化疗反应密切相关。